JEANINE SHOWALTER: Open Payments
NPI 1306952379 · OVERLAND PARK, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$571 in 26 payments from 10 companies in 2025. Trend: 2023 $50 · 2024 $348 · 2025 $571
Food & beverage: $571
| Company | Payments | Amount |
|---|---|---|
| Merck Sharp & Dohme LLC | 5 | $123 |
| GlaxoSmithKline, LLC. | 5 | $102 |
| Genentech USA, Inc. | 3 | $75 |
| Eisai Inc. | 4 | $66 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $54 |
| Novartis Pharmaceuticals Corporation | 2 | $51 |
| Astellas Pharma US Inc | 2 | $44 |
| PharmaEssentia USA Corporation | 1 | $21 |
| Daiichi Sankyo Inc. | 1 | $19 |
| Novocure Inc. | 1 | $17 |
Products named: KEYTRUDA, JEMPERLI, Lenvima, KISQALI, Tecentriq, Vyloy, Polivy, ALUNBRIG.
Industry payments across KS — which companies pay providers there.
